Rich Fante and Marion McCourt promoted at AstraZeneca
This article was originally published in Scrip
Rich Fante, president of AstraZeneca's US business, has been named regional vice-president of the Americas in addition to his current duties. He will be responsible for overseeing operations in Central America and South America. Meanwhile, Marion McCourt, chief executive of AstraZeneca Canada since March 2010, has been made chief operating officer of the US business, effective at the beginning of 2012.
You may also be interested in...
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.